Figure 3From: Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical viewProgression-free survival and overall survival according to KRAS mutation and type of chemotherapy. A - progression-free survival; B – overall survival.Back to article page